-
Istanbul mayor ejected from court in corruption case
-
Family of last woman executed in UK wins posthumous pardon
-
Landslide kills eight at refugee school in Bangladesh
-
'Serial killer' German doctor given life sentence for 15 murders
-
Cleary leads NSW past Queensland to regain State of Origin crown
-
What is going on with Farage's UK election gambit?
-
MEXC Adds Nine Ondo Tokenized Stock and ETF Trading Pairs Tied to AI Infrastructure Demand
-
Dalic quits after 'incredible era' as Croatia coach
-
Oil prices surge, stocks slide as Trump says Iran ceasefire over
-
Bayeux tapestry to arrive in London in secret, high-stakes operation
-
Sunken wrecks, hot seas threaten fishermen on Italian isle
-
Messi World Cup magic masks familiar penalty frailty
-
Rescuers search for survivors of China storms as super typhoon nears
-
Trump lashes out at allies as key NATO summit begins
-
Egypt file complaint against referee after controversial World Cup exit
-
Swiss party into the night after reaching World Cup quarter-finals
-
Apple loses challenge against EU digital competition rules
-
Trump says Iran ceasefire 'over' after fighting flares
-
Trump says Iran ceasefire 'is over'
-
Thai beer dynasty mother drops 'ungrateful child' case against son
-
Rescuers search for missing in China storms after 100,000 flee
-
France v Morocco rematch as World Cup quarter-finals get under way
-
OpenAI to launch new model after US freeze
-
Modi visits Australia for minerals talks and rockstar welcome
-
UK museums at 'sharp end' of climate change challenge
-
Sensors, early starts: how Spain keeps working when heat hits
-
In Mauritania, Imraguen people's desert-ocean paradise under threat
-
Kenya Rastafarians hope for freedom to smoke
-
Iraq's holy cities host funeral processions for Khamenei
-
Pacific nation of Tuvalu condemns Chinese missile launch into Pacific
-
Rescuers search for missing in China storms after 100,000 evacuated
-
How a viral post sparked India's Gen-Z protest
-
Ex-Australia cricketer MacGill loses appeal against cocaine conviction
-
Cambodia wants to bring tigers back, but should it?
-
Oil prices extend rally as US strikes on Iran revive geopolitical fears
-
Chinese repairwomen smash stereotypes with power tools
-
Iraq's holy cities to host funeral processions for Khamenei
-
Ecuador's Death Canal: watery grave for victims of gang violence
-
In Venezuela's quake ruins, a baby is born
-
'Unique event': Solar eclipse fever fills empty Spain
-
What to know about the total solar eclipse due in August
-
Venezuela says Caracas airport to reopen to commercial flights 'soon as possible'
-
Trump, NATO allies to begin key talks at Turkey summit
-
World Cup: Eight teams remain in the hunt for glory
-
Former Real Madrid coach Arbeloa named Fulham manager
-
'A nice surprise': Marathon man Djokovic revels in Wimbledon epic
-
Messi inspires Argentina great escape over Egypt, Swiss advance
-
Switzerland beat Colombia on penalties to reach World Cup quarter-finals
-
US strikes Iran after Hormuz attacks, Tehran threatens response
-
Djokovic survives Wimbledon's longest quarter-final to book Sinner blockbuster
US family reaches deal over cells harvested in 1950s
A US biotechnology company has reached a settlement with the family of Henrietta Lacks, an African-American woman whose cells were used for groundbreaking medical research without her consent.
Civil rights attorney Ben Crump, who filed a lawsuit in 2021 on behalf of the Lacks' estate, announced on Tuesday that the family had agreed a confidential deal with Massachusetts-based firm Thermo Fisher Scientific.
"The parties are pleased that they were able to find a way to resolve this matter outside of court," Crump said, noting that Tuesday would have been Lacks' 103rd birthday.
Crump, who has represented the family of George Floyd and other Black victims of US police violence, said the settlement provides "some measure of justice for Henrietta Lacks, 70 years later."
The 31-year-old Lacks, a tobacco farmer from Virginia and mother of five, died of cervical cancer in 1951 at Johns Hopkins Hospital in Baltimore.
During attempts to cure her shortly before she died, Lacks' abnormally resilient cancer cells were removed from her tumor and were used for decades by researchers without her family's knowledge.
The cells, dubbed HeLa for the first letters of her first and last names, were the first-ever human cells to grow endlessly in the lab -- all others harvested up to that point died.
- Nobel Prizes -
Research using the cells led to Nobel Prize-winning discoveries, and laboratories worldwide used them to develop vaccines -- notably against polio -- as well as in cloning, in-vitro fertilization and many medicines, fueling an industry now worth billions of dollars.
The family knew nothing of Lacks' role until the 1970s, and only came to understand its full scope thanks to the work of Rebecca Skloot, author of the 2010 bestseller "The Immortal Life of Henrietta Lacks."
Lacks' story was also the subject of an HBO movie starring Oprah Winfrey.
"They treated her like a specimen, like a lab rat," her grand-daughter Kimberly Lacks said in 2021, describing the cell theft as racism.
Thermo Fisher Scientific confirmed the settlement, using the same language as the family lawyers Crump and Chris Seeger.
In filing the lawsuit in 2021, Seeger said that Thermo Fisher was the first of many companies that could face legal action for having "profited from the use" of the HeLa cells.
On its website, Johns Hopkins Hospital said that it has never sold or benefited from the discovery or distribution of HeLa cells, and does not own the rights to them.
"HeLa cells were offered freely and widely by Johns Hopkins for scientific research," it said.
"Johns Hopkins has worked in close coordination with several members of the Lacks family over the past decade to recognize and honor Henrietta Lacks, including scholarships, engagement with local schools and annual symposia," it added.
Y.Bouchard--BTB